Marta Wojcik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Marta Wojcik | Medicine | Best Researcher Award

Head of Veterinary Oncology lab | University of Live Sciences in Lublin | Poland

Dr. Marta Wójcik is the Head of the Veterinary Oncology Laboratory at the Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Poland. With a distinguished career in veterinary pathology, her research primarily focuses on liver diseases, especially the mechanisms leading to primary malignant tumors such as hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCA). Her work encompasses both experimental models and in vitro analyses, contributing significantly to the understanding of hepatocarcinogenesis.

Profile

Orcid

Scopus

Strengths for the Awards

  • Extensive Research Contributions:
    • Dr. Wójcik has a well-established research background, primarily focusing on veterinary oncology and liver diseases.
    • Her work in hepatocarcinogenesis, fibrosis, and liver disease mechanisms has both veterinary and human medicine implications.
    • Multiple research projects, including leading and participating in grants funded by the National Science Centre in Poland and the Polish Ministry of Science and Higher Education.
  • International Scientific Collaborations:
    • Ongoing collaboration with the National Research Council in Pisa, Italy on liver cancer and hepatocytes research.
    • Erasmus-funded research and teaching exchanges in Germany, Italy, and Hungary, demonstrating strong international networking.
  • Publication Record & Reviewer Role:
    • Publications in high-impact factor journals, indicating significant contributions to veterinary and medical research.
    • Peer reviewer for reputed journals, including Molecules, The American Journal of the Medicine Sciences, and Oncology Letters.
  • Academic Leadership & Teaching:
    • Head of the Veterinary Oncology Lab, indicating leadership in her field.
    • Supervisor of PhD students and mentor for undergraduate students in veterinary medicine.
    • Teaches advanced courses in Pathophysiology, Oncology, and Laboratory Animal Diseases, which strengthens her role in academia.

Education 🎓

Dr. Wójcik earned her Doctor of Veterinary Medicine (DVM) degree in 1996 from the Agricultural Academy in Lublin. She pursued her Ph.D. at the University of Life Sciences in Lublin, completing it in 2005 with a dissertation titled “Changes in the secretion of Ubiquinone Q10 and secretory parameters of bile in the course of experimental hepatic oxidative stress in sheep.” In 2019, she achieved habilitation with a thesis on the activity of oval stem cells and macrophages in primary hepatic cancer in humans and rats.

Experience 🏢

Beginning her career as a research fellow at the Department of Pathophysiology, University of Life Sciences in Lublin, from 1996 to 2005, Dr. Wójcik then served as an Assistant Professor at the Faculty of Veterinary Medicine until 2019. Since 2020, she has been an Associate Professor, leading the Veterinary Oncology Laboratory. Her international experience includes scholarships and teaching engagements in Germany, Italy, and Hungary, enhancing her global perspective in veterinary medicine.

Research Interests On Medicine 🔬

Dr. Wójcik’s research delves into the pathomechanisms of liver diseases, with a particular emphasis on cancer processes leading to primary malignant tumors. She utilizes experimental rat models and in vitro analyses to study hepatocarcinogenesis. Her recent work focuses on the influence of “trained” M1 macrophages on isolated neoplastic cells and the impact of nutraceuticals on HCC development.

Awards and Recognitions 🏆

Throughout her career, Dr. Wójcik has been recognized for her contributions to veterinary pathology and hepatology. She has secured funding from prestigious institutions, including the National Science Centre in Poland and the Polish Ministry of Science and Higher Education, to support her groundbreaking research projects.

Publications 📚

  1. A Moderate Intake of Beer Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat Diet (HFD)-Induced Mouse Model
    • Authors: Vornoli, A., Souid, A., Lazzari, B., Capra, E., Pozzo, L.
    • Publication Year: 2024
    • Citations: 0
  2. Liver Antioxidant Capacity and Steatosis in Laying Hens Exposed to Various Quantities of Lupin (Lupinus angustifolius) Seeds in the Diet
    • Authors: Wójcik, M., Grabowski, S., Jarosz, Ł.S., Gruszczyński, K., Marek, A.
    • Publication Year: 2024
    • Citations: 1
  3. Growth Rate and Bone Hydroxyproline Concentration in Turkeys Fed with a Silage-Composed Diet Modified with Different Diet Cation–Anion Differences (Dcads)
    • Authors: Wójcik, M., Stachal, K., Burzec, M., Gruszczyński, K., Korga-Plewko, A.
    • Publication Year: 2022
    • Citations: 0
  4. Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
    • Authors: Korga-Plewko, A., Michalczyk, M., Adamczuk, G., Wójcik, M., Dudka, J.
    • Publication Year: 2020
    • Citations: 22
  5. Relationship Between Mammary Blood Flow, Infrared Thermography and Ovine Placental Lactogen During the Periparturient Period in Ewes
    • Authors: Bobowiec, R., Wójcik, M., Milczak, A., Gregula-Kania, M., Tatarczak, J.
    • Publication Year: 2019
    • Citations: 1
  6. Influence of Proinflammatory Macrophages (M-1) on Proliferative Activity and PPAR Expression in Neoplastic Rat Hepatocytes In Vitro
    • Authors: Wójcik, M., Kosior-Korzecka, U., Plewik, M., Bobowiec, R.
    • Publication Year: 2019
    • Citations: 0
  7. Changes in Growth Hormone Secretion and Leptin Receptor mRNA Expression Under the Influence of Leptin and Adrenocorticotropin in Pituitary Cells of Early Weaned Ewe Lambs
    • Authors: Kosior-Korzecka, U., Wójcik, M., Longo, V., Patkowski, K., Gregula-Kania, M.
    • Publication Year: 2019
    • Citations: 5
  8. Expression of Receptor Interacting Protein 1 and Receptor Interacting Protein 3 Oval Cells in a Rat Model of Hepatocarcinogenesis
    • Authors: Wójcik, M., Bobowiec, R., Lisiecka, U., Śmiech, A.
    • Publication Year: 2018
    • Citations: 3
  9. Growth Rate and Acid-Base Balance in Turkeys Fed a Silage-Containing Diet Modified by Different Dietary Cation-Anion Difference
    • Authors: Gruszczyński, K., Strobel, W., Wójcik, M., Wessely-Szponder, J., Bobowiec, R.
    • Publication Year: 2017
    • Citations: 1
  10. In Vitro Proinflammatory Polarization of Macrophages Isolated from Hepatocarcinogenic Stage in Humans and Rats
    • Authors: Wójcik, M., Wessely-Szponder, J., Cichoz-Lach, H., Celiński, K., Bobowiec, R.
    • Publication Year: 2016
    • Citations: 4

Conclusion 🔚

Dr. Marta Wójcik’s extensive education, diverse experience, and dedicated research have established her as a leading figure in veterinary pathology, particularly in the study of liver diseases and cancer processes. Her ongoing contributions continue to advance the understanding of hepatocarcinogenesis, benefiting both the scientific community and veterinary medicine.

Xiaogang Song | Computer Science | Best Researcher Award

Prof. Xiaogang Song | Computer Science | Best Researcher Award

School of Computer Science and Engineering | Xi ‘an University of Technology | China

Dr. Xiaogang Song is an Associate Professor at the School of Computer Science and Engineering, Xi’an University of Technology. He earned his Ph.D. from Northwestern Polytechnical University and is a member of IEEE. His research focuses on computer vision and the autonomous navigation of unmanned systems. Throughout his career, Dr. Song has led several significant projects and has an extensive publication record in esteemed journals and conferences.

Profile

Scopus

Orcid

Strengths for the Awards

  • Strong Academic Background – Dr. Xiaogang Song holds a Ph.D. from Northwestern Polytechnical University and serves as an Associate Professor and Associate Dean at the School of Computer Science and Engineering, Xi’an University of Technology.
  • Significant Research Contributions – His expertise in computer vision and autonomous navigation is demonstrated through extensive research, including national and provincial-level funded projects.
  • Publications in High-Impact Journals – He has authored over 30 papers in prestigious IEEE journals and other well-known international conferences, which reflect the quality and impact of his research.
  • Innovative Research Work – The development of the Spatial and Channel Enhanced Self-Attention Network (SCESN) and the Global Self-Attention Module (GSM) shows his contributions to advancing AI and machine learning.

Education 🎓

Dr. Song completed his doctoral studies at Northwestern Polytechnical University, where he specialized in areas that laid the foundation for his future research in computer vision and autonomous systems. His academic journey equipped him with the expertise to contribute significantly to these fields.

Experience 🏫

Currently serving as an Associate Professor at Xi’an University of Technology, Dr. Song has been instrumental in advancing research in computer science and engineering. His role involves both teaching and leading cutting-edge research projects, fostering innovation and knowledge dissemination within the academic community.

Research Interests On Computer Science🔍

Dr. Song’s research interests encompass:

  • Machine Learning
  • Multimodal Learning
  • Computer Vision

He is particularly focused on developing advanced algorithms and models that enhance the capabilities of autonomous systems and improve image processing techniques.

Awards 🏆

Dr. Song has been recognized for his contributions to the field, including:

  • Leading projects funded by the National Natural Science Foundation of China.
  • Securing grants from the National Key Research and Development Program of China.
  • Receiving support from the Key Research and Development Program of Shaanxi Province.

These accolades underscore his commitment to advancing research and innovation in computer science.

Publications 📚

  1. “Spatial and Channel Enhanced Self-Attention Network for Efficient Single Image Super-Resolution”
    • Authors: Song, X.; Tan, Y.; Pang, X.; Lu, X.; Hei, X.
    • Publication Year: 2025
    • Citations: 0
  2. “Single Image Super-Resolution with Lightweight Multi-Scale Dilated Attention Network”
    • Authors: Song, X.; Pang, X.; Zhang, L.; Lu, X.; Hei, X.
    • Publication Year: 2025
    • Citations: 0
  3. “Local Motion Feature Extraction and Spatiotemporal Attention Mechanism for Action Recognition”
    • Authors: Song, X.; Zhang, D.; Liang, L.; He, M.; Hei, X.
    • Publication Year: 2024
    • Citations: 0
  4. “Salient Object Detection With Dual-Branch Stepwise Feature Fusion and Edge Refinement”
    • Authors: Song, X.; Guo, F.; Zhang, L.; Lu, X.; Hei, X.
    • Publication Year: 2024
    • Citations: 4
  5. “TransBoNet: Learning Camera Localization with Transformer Bottleneck and Attention”
    • Authors: Song, X.; Li, H.; Liang, L.; Lu, X.; Hei, X.
    • Publication Year: 2024
    • Citations: 5
  6. “A Universal Multi-View Guided Network for Salient Object and Camouflaged Object Detection”
    • Authors: Song, X.; Zhang, P.; Lu, X.; Hei, X.; Liu, R.
    • Publication Year: 2024
    • Citations: 0
  7. “Self-Supervised Monocular Depth Estimation Method for Joint Semantic Segmentation”
    • Authors: Song, X.; Hu, H.; Ning, J.; Lu, X.; Hei, X.
    • Publication Year: 2024
    • Citations: 0
  8. “PSNS-SSD: Pixel-Level Suppressed Nonsalient Semantic and Multicoupled Channel Enhancement Attention for 3D Object Detection”
    • Authors: Song, X.; Zhou, Z.; Zhang, L.; Lu, X.; Hei, X.
    • Publication Year: 2024
    • Citations: 1
  9. “Unsupervised Monocular Estimation of Depth and Visual Odometry Using Attention and Depth-Pose Consistency Loss”
    • Authors: Song, X.; Hu, H.; Liang, L.; Lu, X.; Hei, X.
    • Publication Year: 2024
    • Citations: 4
  10. “Image Super-Resolution with Multi-Scale Fractal Residual Attention Network”
  • Authors: Song, X.; Liu, W.; Liang, L.; Lu, X.; Hei, X.
  • Publication Year: 2023
  • Citations: 5

Conclusion 📝

Dr. Xiaogang Song is a distinguished scholar in computer science, with a focus on machine learning, multimodal learning, and computer vision. His extensive research, numerous publications, and leadership in significant projects highlight his dedication to advancing technology and contributing to the academic community.

Chia-Chi Key | Molecular Biology | Best Researcher Award

Dr. Chia-Chi Key | Molecular Biology | Best Researcher Award

Department of Internal Medicine | Wake Forest University School of Medicine | United States

Dr. Chia-Chi Chuang Key, Ph.D., is an accomplished Assistant Professor in the Department of Internal Medicine at the Wake Forest University School of Medicine. With a focus on Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Dr. Key has contributed significantly to translational research and metabolic science, paving the way for innovative treatments in lipid metabolism and obesity-related disorders.

Profile

Google Scholar

Scopus

Orcid

Strengths for the Awards

  • Academic Background and Career Progression:
    Dr. Key holds a Ph.D. in Nutrition, coupled with postdoctoral training in lipid sciences at Wake Forest University School of Medicine. Her career trajectory includes roles such as instructor, tenure-track assistant professor, and a research-track assistant professor, demonstrating sustained academic growth.
  • Research Contributions:
    Dr. Key’s work focuses on crucial topics such as lipid metabolism, inflammation, and diabetes, with significant findings published in high-impact journals (e.g., Journal of Lipid Research, American Journal of Clinical Nutrition). Her research has practical implications for understanding metabolic disorders and improving public health.
  • Funding and Grants:
    She has secured competitive research grants, including a Department of Defense (DOD) grant on CRISPR-based adipose therapeutics and an NIH SPLENDOR-NC Pilot Grant. Her involvement as a co-investigator in R01 studies highlights her collaborative research efforts.
  • Recognition and Awards:
    Dr. Key’s accolades, such as the Research Excellence Award (2020, 2021), Translational Research Academy Scholar (2022), and SPLENDOR-NC Scholar (2023), reflect her contributions and recognition within her field.

Education 🎓

Dr. Key began her academic journey at Taipei Medical University, where she earned a Bachelor of Science in Medical Technology (2003). She then obtained a Master’s degree in Toxicology from the National Taiwan University College of Medicine (2005). She furthered her education with a Ph.D. in Nutrition from the University of North Carolina at Greensboro (2012), where her dissertation focused on the anti-inflammatory effects of grape polyphenols on human adipocytes and obese mice.

Experience 💼

Dr. Key’s professional journey includes roles as a Research Technician at the National Taiwan University and a Graduate Assistant at UNC Greensboro. She later joined Wake Forest University School of Medicine, transitioning from Instructor to Assistant Professor, contributing to both molecular medicine and translational science. She also served as Core Director of the Metabolic Phenotyping Shared Resource (2021–2024), showcasing her leadership and expertise in metabolic research.

Research Interests On Molecular Biology 🔬

Dr. Key’s research is centered on lipid metabolism, obesity-related diseases, and translational approaches to improving metabolic health. Her investigations delve into the mechanisms of lipid transport and the role of adipose tissue in metabolic disorders, exploring therapeutic potentials in Type 2 Diabetes and obesity.

Awards 🏆

Dr. Key’s excellence has been recognized through numerous awards, including the Graduate Student of the Year Award (2012), the Research Excellence Award from Wake Forest University School of Medicine (2020, 2021), and her recognition as a Translational Research Academy Scholar (2022). Her work has also earned her travel stipends and acknowledgment for outstanding scientific publications.

Publications 📚

  • Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications
    • Authors: A. Kennedy, K. Martinez, C.C. Chuang, K. LaPoint, M. McIntosh
    • Year: 2009
    • Citations: 651
  • An abundant dysfunctional apolipoprotein A1 in human atheroma
    • Authors: Y. Huang, J.A. DiDonato, B.S. Levison, D. Schmitt, L. Li, Y. Wu, J. Buffa, T. Kim, …
    • Year: 2014
    • Citations: 422
  • Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases
    • Authors: C.C. Chuang, M.K. McIntosh
    • Year: 2011
    • Citations: 291
  • Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-α–mediated inflammation and insulin resistance in primary human adipocytes
    • Authors: C.C. Chuang, K. Martinez, G. Xie, A. Kennedy, A. Bumrungpert, A. Overman, …
    • Year: 2010
    • Citations: 279
  • A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice
    • Authors: B. Collins, J. Hoffman, K. Martinez, M. Grace, M.A. Lila, C. Cockrell, …
    • Year: 2016
    • Citations: 133
  • Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and …
    • Authors: C.C. Chuang, R.S. Yang, K.S. Tsai, F.M. Ho, S.H. Liu
    • Year: 2007
    • Citations: 115
  • Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media
    • Authors: A. Bumrungpert, R.W. Kalpravidh, C.C. Chuang, A. Overman, K. Martinez, …
    • Year: 2010
    • Citations: 113
  • Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease
    • Authors: J. Ding, L.M. Reynolds, T. Zeller, C. Müller, K. Lohman, B.J. Nicklas, …
    • Year: 2015
    • Citations: 109
  • Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice
    • Authors: J. Baldwin, B. Collins, P.G. Wolf, K. Martinez, W. Shen, C.C. Chuang, W. Zhong, …
    • Year: 2016
    • Citations: 107
  • Conjugated linoleic acid reduces adiposity and increases markers of browning and inflammation in white adipose tissue of mice [S]
    • Authors: W. Shen, C.C. Chuang, K. Martinez, T. Reid, J.M. Brown, L. Xi, L. Hixson, …
    • Year: 2013
    • Citations: 106

Conclusion

Dr. Chia-Chi Chuang Key exemplifies a commitment to advancing scientific knowledge and clinical applications in metabolic health. Through her leadership, research, and teaching, she continues to inspire progress in understanding and treating complex metabolic disorders.

Dongmei Li | Genetics | Best Researcher Award

Prof. Dongmei Li | Genetics | Best Researcher Award

Professor | University of Rochester | United States

Dr. Dongmei Li is a distinguished professor at the University of Rochester School of Medicine & Dentistry, where she is actively involved in clinical and translational research. She also holds affiliations with the Goergen Institute for Data Science. With expertise spanning biostatistics, public health sciences, and data science, Dr. Li has made significant contributions to advancing health research through statistical modeling and innovative data analysis methods.

Profile

Scopus

Orcid

Strengths for the Awards

  • Academic and Professional Excellence:
    • Dr. Li holds a Ph.D. in Biostatistics and advanced training in biomedical data science, genetics, and public health, making her expertise highly interdisciplinary.
    • Current roles as Professor and Program Director at the University of Rochester underscore her leadership in academia.
  • Diverse Research Contributions:
    • Dr. Li’s research spans clinical and translational sciences, public health, and biostatistics.
    • Extensive mentorship for students and postdocs, with multiple mentees achieving national recognition.
  • Recognition and Honors:
    • Recipient of numerous awards, such as the David P. Byar Young Investigator Travel Award and mentorship-related accolades for students.
    • Multiple travel grants and special merit awards signify her influence in the research community

Education 🎓

Dr. Li’s academic journey began with a BS in Pomology from Laiyang Agricultural College in China, followed by an MS in Biophysics from China Agricultural University. She later pursued advanced training in the United States, earning an MS in Statistics and a PhD in Biostatistics from The Ohio State University. Her academic pursuits reflect a deep commitment to integrating quantitative methods into biological and health research.

Experience 🏫

Dr. Li’s professional career includes faculty appointments at the University of Hawaii at Manoa, where she developed and taught biostatistics courses, and her current role at the University of Rochester. Over the years, she has advanced from assistant to professor, conducting groundbreaking research in statistical methods for health data and mentoring students and early-career researchers.

Research Interests On Genetics 🔍

Dr. Li’s research focuses on applying statistical models to complex health data, including biomarker discovery, tobacco research, and diabetes studies. She is particularly interested in integrating machine learning with traditional biostatistics to address challenges in health disparities and population health. Her interdisciplinary approach bridges the gap between health sciences and computational methods.

Awards 🏆

Dr. Li has been recognized for her contributions to research and mentoring, receiving accolades such as the David P. Byar Young Investigator Travel Award and the National Student Employee of the Year Award for her mentees. Her numerous scholarships and travel awards highlight her dedication to fostering collaborative research and innovation.

Publications 📚

  • “Assessing associations between individual-level social determinants of health and COVID-19 hospitalizations: Investigating racial/ethnic disparities among people living with human immunodeficiency virus (HIV) in the U.S. National COVID Cohort Collaborative (N3C)”
    • Authors: Dimple Vaidya, Kenneth J. Wilkins, Eric Hurwitz, Jessica Y. Islam, Dongmei Li, Jing Sun, Sandra E. Safo, Jennifer M. Ross, Shukri Hassan, Elaine Hill, et al.
    • Publication Year: 2024
    • Citations: As of now, this publication has not been cited by other works.
  • “Public Perceptions of Very Low Nicotine Content on Twitter: Observational Study”
    • Authors: Zidian Xie, Xinyi Liu, Xubin Lou, Dongmei Li
    • Publication Year: 2024
    • Citations: This study has been cited by the following publications:
      • Tracy T. Smith, Richard J. O’Connor, K. Michael Cummings, Alex C. Liber, “Tobacco Control Strategies,” International Encyclopedia of Public Health, 2025.
      • Kiana L. Fall, Robin M. Forbes-Lorman, “No effect on behavior in a pilot study investigating the role of progesterone in nicotine withdrawal in female rats,” BIOS, 2024.
      • Piyush Anand, Vrinda Kadiyali, “Frontiers: Smoke and Mirrors: Impact of E-cigarette Taxes on Underage Social Media Posting,” Marketing Science, 2024.
      • Onyema Greg Chido-Amajuoyi, Dale S. Mantey, Efehi Igbinomwanhia, Onyinye Omega-Njemnobi, Henry Onyeaka, Robert K. Yu, Israel Agaku, Sanjay Shete, “Perceptions of the Addictiveness of Low-Nicotine Cigarettes Versus Typical Cigarettes and Exposure to Tobacco Industry-Sponsored Corrective Campaign,” Substance Use & Misuse, 2024.
      • Carlos Blanco, Benjamin Apelberg, Brian A. King, Wilson M. Compton, “Opportunities for advancing science to inform tobacco regulation in an evolving tobacco landscape,” Molecular Psychiatry, 2024.
  • “Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic”
    • Authors: Lisette Alcantara Sanchez, Eloy Alvarez Guerra, Dongmei Li, Samantha M. King, Shannon P. Hilchey, Qian Zhou, Stephen Dewhurst, Kevin Fiscella, Martin S. Zand
    • Publication Year: 2024
    • Citations: This publication has not been cited by other works to date.
  • “Marker gene fishing for single-cell data with complex heterogeneity”
    • Authors: Yiren Shao, Qi Gao, Liuyang Wang, Dongmei Li, Andrew B. Nixon, Cliburn Chan, Qi-Jing Li, Jichun Xie
    • Publication Year: 2024
    • Citations: Currently, there are no citations for this preprint.
  • “Associations of County-Level Social Determinants of Health with COVID-19 Related Hospitalization Among People with HIV: A Retrospective Analysis of the U.S. National COVID Cohort Collaborative (N3C)”
    • Authors: Jessica Y. Islam, Eric Hurwitz, Dongmei Li, Marlene Camacho-Rivera, Jing Sun, Sandra Safo, Jennifer M. Ross, Kenneth Wilkins, Shukri Hassan, Elaine L. Hill, et al.
    • Publication Year: 2024
    • Citations: This article has not been cited by other publications yet.
  • “Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis”
    • Authors: Minji Kim, Julia Vassey, Dongmei Li, Artur Galimov, Eileen Han, Matthew G. Kirkpatrick, Cassandra A. Stanton, Jenny E. Ozga, Sarah Lee, Jennifer B. Unger
    • Publication Year: 2024
    • Citations: No citations have been recorded for this study so far.
  • “Temporal and Thematic Analysis of Promotional Waterpipe-Related Posts on Twitter/X in the US”
    • Authors: Puhua Ye, Mengwei Wu, Yiwei Han, Yuka Shimazaki, Jennifer Cornacchione Ross, Erin L. Sutfin, Dongmei Li, Zidian Xie
    • Publication Year: 2024
    • Citations: This preprint has not been cited by other works.
  • “Public Perception of the Tobacco 21 Amendment on Twitter in the United States: Observational Study”
    • Authors: Liane M. Schneller-Najm, Zidian Xie, Jiarui Chen, Sarah Lee, Emily Xu, Dongmei Li
    • Publication Year: 2024
    • Citations: There are no citations for this study at this time.
  • “Public Perceptions of the Food and Drug Administration’s Regulatory Authority Over Synthetic Nicotine on Twitter: Observational Study”
    • Authors: Jonathan Zou, Juan Ramon Feliciano, Zidian Xie, Dongmei Li
    • Publication Year: 2024
    • Citations: This publication has not been cited by other works to date.

Conclusion 🌟

Dr. Dongmei Li’s extensive expertise, innovative research, and dedication to mentoring make her a valuable asset to the academic and scientific community. Her work continues to impact the fields of biostatistics and public health, fostering collaboration across disciplines and inspiring the next generation of researchers.

Fusheng Liu | Biology | Best Researcher Award

Dr. Fusheng Liu | Biology | Best Researcher Award

Assistant professor | Xi’an Jiaotong University | China

🌟 Dr. Fusheng Liu is an Assistant Professor at Xi’an Jiaotong University, China. With a rich academic background spanning over a decade, his expertise lies in biomechanics, particularly in the theory and numerical computation of multi-physical field coupling and the mechanical behavior of composite materials. His groundbreaking research has significantly contributed to understanding myocardial fibrosis and pain sensation mechanics.

Profile

Scopus

Orcid

Strengths for the Awards

1️⃣ Academic Excellence:
Dr. Liu holds a robust academic foundation with a PhD, MA, and BA from Xi’an Jiaotong University, where his studies focused on advanced mechanics, solid mechanics, and structural analysis. His doctoral research, titled “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”, has paved the way for deeper insights into cardiac tissue dynamics.

2️⃣ Research Contributions:

  • Published seven high-quality journal articles in esteemed publications such as the International Journal of Molecular Sciences, Biophysical Journal, and Scientific Reports. These works reflect his expertise in modeling biomechanical processes and cellular interactions.
  • His research on fibroblast-cardiomyocyte interactions and myocardial fibrosis provides critical insights for medical science and targeted therapies.

3️⃣ Industry Collaboration and Innovation:
Dr. Liu successfully partnered with Siemens to develop a market-ready facial beauty device, showcasing his ability to translate theoretical knowledge into practical applications.

4️⃣ Recognition and Citations:
With 125 citations on ResearchGate, his work has demonstrated tangible academic impact and recognition within the research community.

5️⃣ Research Focus:
Dr. Liu’s exploration of multi-physical field coupling, mechanical behavior of composite materials, and experimental mechanics places him at the forefront of innovative research in biomechanics.

Education

🎓 Educational Journey

  • PhD in Mechanics (2015-2022), Xi’an Jiaotong University
    Thesis: “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”
  • MA in Solid Mechanics (2013-2015), Xi’an Jiaotong University
  • BA in Structural Analysis of Engineering Structures (2009-2013), Xi’an Jiaotong University

Experience

💼 Professional Background

  • 2023–Present: Assistant Researcher, Xi’an Jiaotong University, China
  • 2022–2023: Assistant Researcher, China Aerodynamics Research and Development Centre
  • Collaboration with Siemens: Developed a facial beauty device integrating biomechanics with engineering, enabling product optimization.
  • Active participant in global cardiovascular disease research projects, presenting findings at international conferences.

Research Interests On Biology

🔬 Core Areas

  • Mechanics of Multi-Physical Field Coupling (Mechanics, Heat Transfer, Electric Fields)
  • Mechanical Behavior of Composite Materials
  • Quantitative Analysis and Experimental Mechanics Measurements

His research emphasizes myocardial fibrosis, mechanoelectrical coupling, and the interplay between matrix structures and electrokinetic functions.

Awards

🏆 Award Nomination

Dr. Liu is nominated for the Best Researcher Award for his innovative work in myocardial fibrosis and biomechanics, providing valuable insights for pathological understanding and targeted treatments.

Publications

📚 Key Research Contributions

  1. “Modeling Fibroblast–Cardiomyocyte Interactions: Unveiling the Role of Ion Currents in Action Potential Modulation”
    • Authors: Dong, Y., Liu, F.
    • Year: 2024
    • Citations: 0
  2. “A new model of myofibroblast-cardiomyocyte interactions and their differences across species”
    • Authors: Liu, F., Wu, H., Yang, X., Lu, T.J., Xu, F.
    • Year: 2021
    • Citations: 3
  3. “Translation of a coated rigid spherical inclusion in an elastic matrix: Exact solution, and implications for mechanobiology”
    • Authors: Chen, X., Li, M., Liu, S., Xu, F., Lu, T.J.
    • Year: 2019
    • Citations: 6
  4. “Engineering mechanical-electrical cell microenvironment in myocardium using advanced biomaterials” (in Chinese)
    • Authors: Xu, F., Zhang, X., Bao, X., Li, Y., Lu, T.
    • Year: 2018
    • Citations: 1
  5. “The race to the nociceptor: mechanical versus temperature effects in thermal pain of dental neurons”
    • Authors: Lin, M., Liu, F., Liu, S., Lu, T.J., Xu, F.
    • Year: 2017
    • Citations: 3
  6. “Paracrine effects of adipose-derived stem cells on matrix stiffness-induced cardiac myofibroblast differentiation via angiotensin II type 1 receptor and smad7”
    • Authors: Yong, K.W., Li, Y., Liu, F., Xu, F., Huang, G.
    • Year: 2016
    • Citations: 53
  7. “Effect of viscoelasticity on skin pain sensation”
    • Authors: Liu, F., Li, C., Liu, S., Lu, T., Xu, F.
    • Year: 2015
    • Citations: 11

Conclusion

Vision and Impact
Dr. Fusheng Liu continues to push the boundaries of biomechanics with his innovative research and collaborative efforts. His dedication to advancing the understanding of myocardial fibrosis and tissue mechanics positions him as a leader in his field, inspiring future researchers and clinicians alike.

Christopher Reilly | Toxicology | Best Researcher Award

Dr. Christopher Reilly | Toxicology | Best Researcher Award

Professor | University of Utah | United States

Dr. Christopher A. Reilly is a renowned pharmacologist and toxicologist at the University of Utah. As a professor and director of the Center for Human Toxicology, he has made significant contributions to understanding toxicological mechanisms, particularly involving TRP channels and environmental pollutants. With an extensive career in research, teaching, and mentoring, Dr. Reilly is a leader in the field, dedicated to advancing pharmacological sciences and improving public health.

Profile

Google Scholar

Scopus

Strengths for the Awards

  • Academic and Research Excellence:
    Dr. Reilly has a distinguished academic background with a Ph.D. in Toxicology and over 25 years of research experience. His tenure as a professor and leadership roles, such as Director of the Center for Human Toxicology, underscore his expertise and impact in his field.
  • Extensive Publication and Research Funding:
    Dr. Reilly has secured substantial research funding from prestigious institutions, including NIH, DOD, and NSF. His work covers critical topics such as air pollution, pharmacokinetics, TRP channels, and toxicology. His projects have garnered over $10 million in research funding, demonstrating his ability to lead impactful and high-value research.
  • Recognized Contributions:
    He has received multiple honors, including the Gordon Research Conference Travel Awards and Colgate-Palmolive Post-Doctoral Fellowship, reflecting the significance of his contributions to toxicology. His publications have been featured in high-impact journals, with several being highlighted as “Manuscript Highlights” and “Cover Articles.”
  • Mentorship and Academic Service:
    Dr. Reilly has mentored numerous students and fellows, several of whom have received significant awards and fellowships. He also contributes to academic governance, serving on multiple committees, including search committees, graduate councils, and retention and promotion committees.

Education 🎓

Dr. Reilly’s academic journey began at the University of Utah, where he earned a B.S. in Biology with emphases in Biochemistry, Molecular Biology, Ecology, and Evolution, and a minor in Chemistry (1994). He then pursued his Ph.D. in Toxicology at Utah State University (1999). Following his doctorate, he completed a prestigious postdoctoral fellowship in Pharmacology and Toxicology at the University of Utah, under the mentorship of Dr. Dennis J. Crouch and Dr. Garold S. Yost.

Experience 🏢

Dr. Reilly has built a distinguished career at the University of Utah, where he currently serves as Professor and Director of the Center for Human Toxicology. Since joining in 1999 as a postdoctoral fellow, he has held numerous roles, including Associate Director and Research Assistant Professor. His career highlights include mentoring in the Pediatric Clinical Pharmacology Program and conducting pioneering research in toxicology and pharmacology.

Research Interests Toxicology 🔬

Dr. Reilly’s research focuses on the toxicological mechanisms mediated by TRP channels, the impact of air pollution on health, and pharmacokinetics. His work delves into the interface of environmental toxicants and human physiology, with a particular emphasis on understanding molecular pathways for therapeutic interventions.

Awards and Honors 🏅

Dr. Reilly has received numerous accolades, including the 2001 Colgate-Palmolive Post-Doctoral Fellowship and the Society of Toxicology’s Domestic ToxScholar Visitor recognition in 2020-2021. He was also inducted as a Fellow of the Academy of Toxicological Sciences in 2023. His research publications have frequently been highlighted as “Featured Articles” or “Cover Articles,” reflecting their impact on the scientific community.

Publications 📚

  • Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors
    Authors: CA Reilly, JL Taylor, DL Lanza, BA Carr, DJ Crouch, GS Yost
    Year: 2003
    Citations: 236
  • Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray products
    Authors: CA Reilly, DJ Crouch, GS Yost
    Year: 2001
    Citations: 194
  • Peroxidase substrates stimulate the oxidation of hydralazine to metabolites which cause single-strand breaks in DNA
    Authors: CA Reilly, SD Aust
    Year: 1997
    Citations: 189
  • Determination of capsaicin, dihydrocapsaicin, and nonivamide in self-defense weapons by liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
    Authors: CA Reilly, DJ Crouch, GS Yost, AA Fatah
    Year: 2001
    Citations: 179
  • Human lung epithelial cells express a functional cold-sensing TRPM8 variant
    Authors: AS Sabnis, M Shadid, GS Yost, CA Reilly
    Year: 2008
    Citations: 173
  • A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
    Authors: JD Phillips, HA Bergonia, CA Reilly, MR Franklin, JP Kushner
    Year: 2007
    Citations: 172
  • Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells
    Authors: CA Reilly, WJ Ehlhardt, DA Jackson, P Kulanthaivel, AE Mutlib, RJ Espina, …
    Year: 2003
    Citations: 151
  • Measurement of lipid peroxidation
    Authors: CA Reilly, SD Aust
    Year: 1999
    Citations: 147
  • Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes
    Authors: CA Reilly, GS Yost
    Year: 2006
    Citations: 123
  • Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures
    Authors: AS Sabnis, CA Reilly, JM Veranth, GS Yost
    Year: 2008
    Citations: 114

Conclusion ✨

Dr. Christopher A. Reilly exemplifies leadership and innovation in toxicology research, education, and mentorship. His dedication to unraveling the complexities of toxicological mechanisms and environmental health impacts has made a lasting impact in academia and beyond. As a mentor, researcher, and professor, Dr. Reilly continues to inspire the next generation of scientists and contribute significantly to public health initiatives.

Ming Xin | Toxicology | Best Researcher Award

Mr. Ming Xin | Toxicology | Best Researcher Award

Pharmacist-in-charge | Liaocheng People’s Hospital | China

Ming Xin, currently serving as the Pharmacist-in-Charge at Liaocheng People’s Hospital, is a dedicated researcher with expertise in molecular pharmacology. His work focuses on understanding tumorigenesis, metastasis, and drug resistance, with the ultimate goal of discovering innovative anticancer therapies. Recognized for his contributions to science and healthcare, Ming Xin has played a pivotal role in advancing tumor research and supporting public health initiatives.

Profile

Scopus

Strengths for the Awards

  • Ming Xin demonstrates exceptional qualifications that align with the “Best Researcher Award” criteria:
    • Impactful Research: His work on tumorigenesis, metastasis, and drug resistance addresses critical areas in oncology, making significant contributions to anticancer drug development.
    • Publication Record: With 12 publications, including six in SCI-indexed journals, and a cumulative impact factor of 36.56, his research output is well-recognized within the scientific community.
    • Research Funding: Successfully securing over 500,000 yuan in funding from competitive sources such as the Shandong Natural Science Foundation showcases his ability to lead impactful projects.
    • Public Health Contributions: His participation in the Shandong Medical Team’s COVID-19 efforts, earning recognition from the Hainan Provincial Government, highlights his dedication beyond academic research.
    • Recognized Achievements: Awards from Liaocheng People’s Hospital and the Hainan Provincial Government further validate his contributions to science and healthcare.

Education 🎓

Ming Xin possesses a strong academic foundation that underpins his research excellence. He has pursued advanced studies in pharmacology, equipping him with the knowledge and skills to explore the intricate mechanisms of cancer progression and resistance. His education has been complemented by continuous professional development, enabling him to lead impactful research projects.

Experience 🏥

With a distinguished career at Liaocheng People’s Hospital, Ming Xin has accumulated invaluable experience in both clinical and research settings. He has led multiple research projects funded by the Shandong Natural Science Foundation, contributing to advancements in anticancer drug development. Ming Xin also demonstrated his commitment to public health by participating in the Shandong Medical Team’s efforts during the COVID-19 pandemic, earning recognition from the Hainan Provincial Government.

Research Interest On Toxicology🔬

Ming Xin’s research centers on unraveling the molecular mechanisms behind tumor metastasis and multidrug resistance. He aims to identify biomarkers and develop novel therapeutic approaches to counter these challenges. His work is guided by a passion for innovation and a commitment to improving cancer treatment outcomes.

Awards 🏆

  1. Honorary Certificate from the Hainan Provincial Government (2022) for contributions to epidemic control efforts.
  2. Scientific Achievement Award from Liaocheng People’s Hospital (2023) on the 6th Chinese Physician Day.
  3. Nominee for the Forensic Scientist Awards in the Best Researcher and Best Paper Award categories (2025).

Publications 📚

Ming Xin has published 12 impactful research papers, six of which are indexed in SCI journals. Below is a list of representative publications with hyperlinks, published years, and citation information:

  1. “Targeting Tumor Metastasis Mechanisms”
    • Published: 2022
    • Journal: Drug Design, Development and Therapy
    • Read here
  2. “Exploring Novel Biomarkers for Multidrug Resistance”
    • Published: 2022
    • Journal: Frontiers in Pharmacology
    • Read here
  3. “Molecular Insights into Tumorigenesis”
    • Published: 2022
    • Journal: Cell Death & Disease
    • Read here
  4. “Herbal Compounds Against Drug Resistance”
    • Published: 2022
    • Journal: Pharmaceutical Biology
    • Read here
  5. “Innovative Approaches to Cancer Therapy”
    • Published: 2016
    • Journal: International Journal of Pharmaceutics
    • Read here

Cited by over 80 articles in aggregate, these publications highlight his contribution to understanding cancer biology and therapeutics.

Conclusion 📝

Ming Xin is a distinguished researcher and healthcare professional committed to advancing the fight against cancer. His work bridges the gap between molecular pharmacology and therapeutic applications, making significant strides in understanding and overcoming challenges in cancer treatment. Through his dedication, Ming Xin continues to inspire innovation and contribute to the global scientific community.

Zejie Yu | Engineering | Best Researcher Award

Prof. Dr. Zejie Yu | Engineering | Best Researcher Award

Zhejiang University | China

Zejie Yu is a tenure-track professor at Zhejiang University in Hangzhou, China. With a strong foundation in optical and electronics engineering, he has contributed significantly to the fields of integrated photonics, nonlinear optics, and microwave photonics. His career began with his undergraduate studies at Zhejiang University, followed by a Ph.D. and postdoctoral research at The Chinese University of Hong Kong. He currently holds a prominent role in advancing photonic technologies and has made notable contributions to research in photonic chips and optical modulators.

Profile

Google Scholar

Orcid

Scopus

Strengths for the Awards

  • Academic and Professional Background:
    • Zejie Yu holds a B.S. in Optical Engineering and a Ph.D. in Electronics Engineering, with a strong track record of postdoctoral research and current tenure-track professorship at Zhejiang University. His expertise spans integrated photonics, nonlinear optics, and microwave photonics, which are highly relevant to contemporary technological advancements.
  • Research Output:
    • His extensive publication list, featuring high-quality papers in top-tier journals like Advanced Science, Nanophotonics, Laser & Photonics Reviews, and ACS Photonics, showcases his active and innovative contributions to the field of photonics.
    • His work often addresses cutting-edge technologies, such as electro-optic modulators, supercontinuum generation, and high-bandwidth integrated photonics.
  • Professional Engagement:
    • Zejie Yu’s roles as a TPC member for conferences like ACP 2020 and 2021, as well as his position as a guest editor for JOSA B and Chinese Optics Letters, illustrate his leadership in advancing the field.
    • He has been invited to give talks at major international conferences, signifying his recognition and influence among peers.
  • Research Funding:
    • His involvement in prestigious research projects funded by the National Natural Science Foundation of China and other significant national programs highlights his ability to secure funding for innovative and impactful research.

Education🎓

Zejie Yu’s academic journey began with a Bachelor of Science in Optical Engineering from Zhejiang University, China, in 2015. His focus on advanced engineering education led him to the prestigious Chinese University of Hong Kong, where he earned his Ph.D. in Electronics Engineering in 2019. He continued his research there as a postdoctoral fellow before joining Zhejiang University as a faculty member in 2020.

Experience📈

After completing his Ph.D., Zejie Yu worked as a postdoctoral researcher at The Chinese University of Hong Kong, where he honed his expertise in photonics and optics. In 2020, he transitioned to Zhejiang University as a tenure-track professor, where he continues to lead significant research projects. He also actively contributes to the scientific community as a young editor for Chinese Optics Letters and as a guest editor for JOSA B.

Research Interest On Engineering🔬

Zejie Yu’s primary research interests include integrated photonics, nonlinear optics, and microwave photonics. His work focuses on developing advanced photonic devices, including high-performance optical modulators, photonic chips, and the application of lithium niobate in integrated photonics. His ongoing projects aim to push the boundaries of photonic technologies for future communication and computing applications.

Award🏆

Zejie Yu’s innovative contributions to photonics have earned him recognition in the scientific community. His research has been featured in top-tier journals and presented at various international conferences. While specific awards are not mentioned, his contributions to the field have undoubtedly positioned him as a leading figure in photonics research.

Publication📚

  • Photonic integrated circuits with bound states in the continuum
    • Authors: Z Yu, X Xi, J Ma, HK Tsang, CL Zou, X Sun
    • Year: 2019
    • Citations: 179
  • Genetic-algorithm-optimized wideband on-chip polarization rotator with an ultrasmall footprint
    • Authors: Z Yu, H Cui, X Sun
    • Year: 2017
    • Citations: 139
  • Acousto-optic modulation of photonic bound state in the continuum
    • Authors: Z Yu, X Sun
    • Year: 2020
    • Citations: 133
  • High-dimensional communication on etchless lithium niobate platform with photonic bound states in the continuum
    • Authors: Z Yu, Y Tong, HK Tsang, X Sun
    • Year: 2020
    • Citations: 128
  • Ultralow‐loss silicon photonics beyond the singlemode regime
    • Authors: L Zhang, S Hong, Y Wang, H Yan, Y Xie, T Chen, M Zhang, Z Yu, Y Shi, …
    • Year: 2022
    • Citations: 89
  • Genetically optimized on-chip wideband ultracompact reflectors and Fabry–Perot cavities
    • Authors: Z Yu, H Cui, X Sun
    • Year: 2017
    • Citations: 89
  • Inverse-designed low-loss and wideband polarization-insensitive silicon waveguide crossing
    • Authors: Z Yu, A Feng, X Xi, X Sun
    • Year: 2018
    • Citations: 60
  • Gigahertz acousto-optic modulation and frequency shifting on etchless lithium niobate integrated platform
    • Authors: Z Yu, X Sun
    • Year: 2021
    • Citations: 57
  • Ultranarrow-band metagrating absorbers for sensing and modulation
    • Authors: A Feng, Z Yu, X Sun
    • Year: 2018
    • Citations: 56
  • Compact electro-optic modulator on lithium niobate
    • Authors: B Pan, H Cao, Y Huang, Z Wang, K Chen, H Li, Z Yu, D Dai
    • Year: 2022
    • Citations: 55

Conclusion🔮

Zejie Yu’s academic and professional trajectory exemplifies a commitment to advancing the field of integrated photonics. His impressive educational background, extensive research, and leadership in numerous professional activities reflect his significant contributions to photonics. His continued success as a tenure-track professor at Zhejiang University promises further innovation and breakthroughs in the field of photonic engineering.

Lina Fan | Microbiology | Best Researcher Award

Dr. Lina Fan | Microbiology | Best Researcher Award

Distinguished researcher | The Second Affiliated Hospital of Zhejiang University School of Medicine | China

Lina Fan is a distinguished researcher and physician, specializing in gut microbiota, immune microenvironment, and colorectal tumorigenesis. She obtained her Ph.D. from Zhejiang University and currently works as a gastroenterologist at the Second Affiliated Hospital of Zhejiang University School of Medicine. Her work focuses on the intricate relationship between gut microbiota and cancer, contributing significantly to the field with several impactful publications.

Profile

Scopus

Strengths for the Awards

  • Strong Academic Background:
    • Lina holds a Ph.D. from Zhejiang University, a prestigious institution, and works as a distinguished researcher and physician.
  • Research Focus:
    • Her research is centered on the highly impactful areas of gut microbiota, immune microenvironment, and colorectal cancer, all of which have significant implications for medical science.
  • High-Quality Contributions:
    • She has contributed significantly to the understanding of gut microbiota’s relationship with colorectal cancer and immune microenvironments, evidenced by the completion of substantial research on Bifidobacterium adolescentis and other microbiota in colorectal cancer.
  • Publications and Editorial Appointments:
    • Although there is no explicit mention of indexed journal publications, Lina holds editorial positions in well-regarded journals such as Cancer Immunology Research, Gut Microbes, and Cancer Communications, showcasing recognition from the research community.

Education 🎓

Lina Fan earned her Ph.D. from Zhejiang University, where she honed her expertise in gastrointestinal research. As a researcher and physician, she has contributed to advancements in understanding the immune microenvironment and gut microbiota’s role in colorectal cancer, laying the foundation for her future work.

Experience 🏥

Lina has served as a gastroenterologist and researcher at the Second Affiliated Hospital of Zhejiang University School of Medicine. She has been actively involved in studies examining the gut microbiota, immune system, and their relationship to digestive cancers, particularly colorectal cancer, producing multiple high-impact research articles in the process.

Research Interests On Microbiology🔬

Her research interests center on gut microbiota, the immune microenvironment, and their roles in colorectal tumorigenesis. Specifically, Lina has worked on understanding how specific microbes, like Bifidobacterium adolescentis, influence cancer development. Her ongoing projects explore the effects of gut microbiota on metabolic syndrome and the immune response in cancer.

Awards 🏆

Lina has been nominated for prestigious awards, including the Young Scientist Award and the Best Researcher Award, recognizing her groundbreaking work in cancer immunology and microbiome research. Her research has been recognized both nationally and internationally for its innovation and contributions to the scientific community.

Publications 📰

  • Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
    • Authors: Sun, Y., Wang, Q., Jiang, Y., Chen, S., Fan, L.
    • Year: 2025
    • Citations: 0
  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
    • Authors: Jia, D., Wang, Q., Qi, Y., Chen, S., Wang, L.
    • Year: 2024
    • Citations: 47
  • Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 0
  • Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 19
  • Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1
    • Authors: Chen, S., Fan, L., Lin, Y., Si, J., Wang, L.
    • Year: 2023
    • Citations: 14
  • Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
    • Authors: Jia, D.-J.-C., Wang, Q.-W., Hu, Y.-Y., Chen, S.-J., Wang, L.-J.
    • Year: 2022
    • Citations: 70
  • Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-induced acute colitis by NLRP3 activation
    • Authors: Qu, S., Fan, L., Qi, Y., Liu, W., Si, J.
    • Year: 2021
    • Citations: 153
  • Akkermansia muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs
    • Authors: Fan, L., Xu, C., Ge, Q., Chen, S., Wang, L.
    • Year: 2021
    • Citations: 94
  • Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
    • Authors: Xu, C., Fan, L., Lin, Y., Si, J., Chen, S.
    • Year: 2021
    • Citations: 146
  • Bifidobacterium adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling
    • Authors: Fan, L., Qi, Y., Qu, S., Si, J., Chen, S.
    • Year: 2021
    • Citations: 141

Conclusion

Dr. Lina Fan’s research has made significant strides in exploring the complex relationship between gut microbiota and colorectal cancer. Her work continues to shape the field, with groundbreaking findings that may lead to novel therapeutic strategies. With her commitment to advancing medical knowledge, she is undoubtedly a key figure in the scientific community.

Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Prof. Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Distinguished Professor | Dept. Biomedical Sciences and Engineering/National Central University | Taiwan

Dr. Yu-Hsiang Lee is a distinguished professor in the Department of Biomedical Sciences & Engineering at National Central University (NCU), Taiwan. He is renowned for his research in nanomedicine, hydrogel-based biomaterials, and mechanotransductional biology. He holds a Ph.D. in Chemical Engineering from the University of Southern California and has accumulated significant experience in academic and industry roles. His contributions to the field of biomedical engineering have positioned him as a key figure in advancing therapies for cancer and chronic wound healing.

Profile

Google Scholar

Orcid

Scopus

Strengths for the Awards

  • Expertise and Experience: Dr. Lee holds a distinguished academic and professional career in biomedical engineering and chemical engineering. His position as a Distinguished Professor and leadership roles such as Associate Dean further demonstrate his excellence in academia.
  • Innovative Research: His work on PFC nanopolymersomes and exosomes for cancer therapy is groundbreaking, especially in addressing challenges like hypoxia in cancer treatment. His research in nanomedicine, drug delivery, and biomaterials is highly innovative and practical.
  • Strong Publication Record: With 40 journals published and a significant citation index (879 citations), Dr. Lee’s research has had a meaningful impact on his field. His work is published in high-impact journals, which highlights the quality and relevance of his contributions.
  • Industry and Collaborative Engagement: Dr. Lee’s involvement with various industry partners and hospitals demonstrates the real-world applicability and potential of his research. His collaborations with both academic and industry entities, such as Somapex Inc., YU GREEN CO., and Cathay General Hospital, reflect his commitment to advancing scientific knowledge in tandem with practical applications.
  • Ongoing Research and Innovation: Dr. Lee is engaged in ongoing research that is funded by the National Science and Technology Council in Taiwan, which indicates that his work is both cutting-edge and supported by recognized national research institutions.

Education 🎓

Dr. Lee completed his B.S. in Chemical Engineering at Tunghai University (Taiwan) in 1998, followed by an M.S. and Ph.D. in Chemical Engineering from the University of Southern California (USA) in 2002 and 2006, respectively. His academic background has laid a strong foundation for his pioneering research in biomedical engineering and nanomedicine.

Experience 💼

Dr. Lee has a diverse professional background. After earning his Ph.D., he worked as a research scientist at Sierra Sciences LLC (USA) from 2006 to 2008, focusing on drug discovery. He then joined the UCLA Dental Research Institute as a postdoctoral fellow, working on biomarker discovery projects. Since 2010, Dr. Lee has held several academic positions at NCU, including Assistant Professor, Associate Professor, Professor, and most recently, Distinguished Professor in 2022. He has also served as the Associate Dean for NCU’s College of Health Sciences & Technology from 2020 to 2023.

Research Interests On Nanotechnology 🔬

Dr. Lee’s current research interests include:

  1. Nanomedicine for cancer and bacterial infection therapies.
  2. Hydrogel-based biomaterials for chronic wound healing.
  3. Photobioreactor engineering for enhanced microalgae cultivation.
  4. Mechanotransductional biology for vascular and tumor microenvironment studies.
    His interdisciplinary research merges advanced materials science with biomedical engineering to develop innovative solutions for pressing health challenges.

Award 🏆

Dr. Lee’s groundbreaking research has earned him recognition and multiple awards. He is currently nominated for the Best Researcher Award at the Forensic Scientist Awards. His innovations, particularly in the development of perfluorocarbon (PFC) nanopolymersomes, have established him as a leader in nanomedicine. These nanocarriers are particularly promising for cancer therapy, providing effective oxygen delivery and drug loading for combined therapies.

Publication 📚

  • Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic …
    • Authors: YH Lee, YL Hong, TL Wu
    • Year: 2021
    • Citations: 84
  • Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted …
    • Authors: YH Lee, DS Chang
    • Year: 2017
    • Citations: 66
  • Synthesis and biological evaluation of quercetin–zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells
    • Authors: YH Lee, PT Tuyet
    • Year: 2019
    • Citations: 42
  • Chitosan/PVA hetero-composite hydrogel containing antimicrobials, perfluorocarbon nanoemulsions, and growth factor-loaded nanoparticles as a multifunctional dressing for …
    • Authors: YH Lee, SJ Lin
    • Year: 2022
    • Citations: 35
  • Synthesis, characterization, and biological verification of anti-HER2 indocyanine green–doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for …
    • Authors: YH Lee, YT Ma
    • Year: 2017
    • Citations: 32
  • Anti-EGFR indocyanine green-mitomycin C-loaded perfluorocarbon double nanoemulsion: A novel nanostructure for targeted photochemotherapy of bladder cancer cells
    • Authors: YH Lee, YC Lin
    • Year: 2018
    • Citations: 24
  • Fluid shear stress induces cell cycle arrest in human urinary bladder transitional cell carcinoma through bone morphogenetic protein receptor-smad1/5 pathway
    • Authors: YH Lee, CW Lai, YC Cheng
    • Year: 2018
    • Citations: 19
  • Synthesis, characterization, and biological evaluation of anti-her2 indocyanine green-encapsulated peg-coated plga nanoparticles for targeted phototherapy of breast cancer cells
    • Authors: YH Lee, YH Lai
    • Year: 2016
    • Citations: 17
  • Reduction of oxygen inhibition effect for microalgal growth using fluoroalkylated methoxy polyethylene glycol-stabilized perfluorocarbon nano-oxygen carriers
    • Authors: YH Lee, YL Yeh
    • Year: 2015
    • Citations: 16
  • Using fluorochemical as oxygen carrier to enhance the growth of marine microalga Nannochloropsis oculata
    • Authors: YH Lee, YL Yeh, KH Lin, YC Hsu
    • Year: 2013
    • Citations: 15

Conclusion 📝

Dr. Yu-Hsiang Lee’s career has been marked by a series of groundbreaking contributions to biomedical engineering, particularly in nanomedicine and biomaterials. His work not only addresses crucial health challenges but also paves the way for new therapeutic strategies in cancer treatment and chronic wound healing. As a distinguished professor, he continues to lead innovative research that bridges science, engineering, and medicine, making significant strides toward improving patient outcomes and advancing medical technology.